Tirzepatide is a dual-action GLP-1/GIP agonist that works by mimicking your bodys natural hormones, helping you feel fuller faster and for longer
doi: 10.3389/fphar.2023.1303844 Received 28 September 2023 Accepted 30 November 2023 Published 11 December 2023 Volume 14 - 2023 Edited by Alessio Squassina, University of Cagliari, Italy Reviewed by Michele Mazzanti, University of Milan, Italy Yashmin Choudhury, Assam University, India Updates Copyright 2023 Greco, Coperchini, Croce, Magri, Teliti and Rotondi
Novo Nordisk has already asked the FDA for approval to sell once-weekly CagriSema injections
Some models used milligrams per kilogram
Some believe that once they stop the medication, theyll regain all the weight